Skip to Main Content

Paper Details

Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients.
Eur Heart J Cardiovasc Pharmacother
55
2020
ADP, CES1, CES1 G143E, CVEs, CYP2B6, CYP2B6 1294+, CYP2B6 1294+53C, CYP2C19*17, CYP2C19*2, CYP2C19*2), CYP2C9*2, CYP2C9*3, Clopidogrel, G143E, ICPC, Patients, PgxRS, adenosine diphosphate, alleles, atherothrombotic events, candidate gene polymorphisms, cardiovascular death, cardiovascular-related death, clopidogrel, coronary artery disease, ischaemic events, patients, platelet, polymorphisms, risk alleles
Author NameAffiliation
Joshua P LewisUniversity of Maryland
Braxton D MitchellUniversity of Maryland
Braxton D MitchellGeriatrics Research and Education Clinical Center, Baltimore Veterans Administration Medical Center
Marylyn D RitchieCenter for Translational Bioinformatics, Institute for Biomedical Informatics, University of Pennsylvania
Marylyn D RitchieCenter for Translational Bioinformatics, Institute for Biomedical Informatics, University of Pennsylvania
Ruth E PakyzUniversity of Maryland
Ruth E PakyzUniversity of Maryland
Li GongStanford University
Eun Young KimInje University, Busan Paik Hospital
Dan M RodenVanderbilt University Medical Center
Dan M RodenVanderbilt University Medical Center
Dan M RodenVanderbilt University Medical Center
Russ B AltmanStanford University
Michiaki KuboRIKEN Center for Integrative Medical Sciences
Matthias Schwab
Matthias SchwabUniversity of Tuebingen
Matthias SchwabDepartment of Pharmacy and Biochemistry, University of Tuebingen
Teri E KleinStanford University
Teri E KleinStanford University
Alan R ShuldinerUniversity of Maryland
Alan R ShuldinerUniversity of Maryland
  • 1 - 21

Datasets

Release 1.2